Bulletin
Investor Alert

April 19, 2022, 2:58 a.m. EDT

Omeprazole Market Size, Share, Trends, Analysis Report And Future Predictions

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Mallee Resources Ltd. (MYL)
  • X
    Amneal Pharmaceuticals Inc. (AMRX)
  • X
    Algernon Pharmaceuticals Inc. (AGN)

or Cancel Already have a watchlist? Log In

Apr 19, 2022 (AmericaNewsHour) -- Research Nester has released a report titled " Omeprazole Market  - Global Demand Analysis & Opportunity Outlook 2027" which also includes some of the prominent market analyzing parameters such as industry growth drivers, restraints, supply and demand risk, market attractiveness, year-on-year (Y-O-Y) growth comparisons, market share comparisons, BPS analysis, SWOT analysis and Porter's five force model.

The regulatory agencies around the world has approved omeprazole drug to be prescribed as a proton pump inhibitor (PPI) that helps in reducing acidity. The drug is also prescribed for curing heartburns and for the treatment of diseases linked with the gastro-esophageal reflux disease (GERD). Additionally, rising number of patients who are suffering from peptic ulcers is also raising the need for the treatment of the gastrointestinal disorders. Moreover, increasing awareness for the treatment of several gastrointestinal disorders in several developed and developing nations around the globe owing to the increasing expenditure by the government of nations for the development of the healthcare infrastructure are some of the factors anticipated to drive the growth of the global omeprazole market.

Download Sample of This Strategic Report @ https://www.researchnester.com/sample-request-2477

The global omeprazole market is anticipated to achieve a CAGR of around 6% during the forecast period, i.e. 2019-2027. The market is thriving on account of the rising number of obese people globally, growing prevalence of acid refluxes, respiratory disorders, heart-related issues and others amongst the growing number of elderly populations, as well as for the increasing opportunities generated from the increasing focus on innovation and development for low-cost generics by the pharmaceutical manufacturers. Further, the market which was valued at a value of around USD 1900 million in the year 2018 is anticipated to achieve an absolute $ opportunity of around USD 1200 million during the forecast period and garner a value of around USD 3300 million by the end of 2027.

The global omeprazole market is segmented by dosage form into capsule, tablet and powder. Among these segments, the capsule segment held a market share of around 52% in the year 2018 and is anticipated to cross a value of around USD 1800 million by the end of 2027. The segment is also anticipated to register the highest CAGR of around 6.5% over the forecast period. Moreover, the tablet segment is anticipated to grow with a moderate CAGR of around 6% over the forecast period.

Request a Sample Copy of Concerned Market Report @ https://www.researchnester.com/sample-request-2477

Geographically, the global omeprazole market is segmented by five major regions into North America, Europe, Middle East & Africa, Asia-Pacific and Latin America region, out of which, North America, which held the largest market share of around 38% in the year 2018, is anticipated to grow on account of presence of nations, such as U.S. and Canada, where U.S. held the dominant market share of around 59% in the year 2018. Moreover, the market is further expected to expand by observing the growth rate of ar0und 1.6x over the forecast period.

However, concerns for the use of alternative drugs, such as antacids, which are also used for the treatment of GERD and to neutralize the acid in the stomach, are some of the factors estimated to act as a barrier to the growth of the global omeprazole market.

This report also studies existing competitive scenario of some of the key players of the global omeprazole market, which includes profiling of Dr. Reddy's Laboratories Ltd. (nse:DRREDDY), AstraZeneca plc (lon:AZN), Sandoz International GmbH, Mylan N.V. /zigman2/quotes/206812383/delayed AU:MYL -2.10% , Apotex, Inc., Amneal Pharmaceuticals LLC /zigman2/quotes/209301288/composite AMRX +5.66% , Perrigo Company plc, Salix Pharmaceuticals and Allergan plc /zigman2/quotes/202813279/delayed CA:AGN +3.89% .

Curious about this latest version of report? Obtain Report Details @ https://www.researchnester.com/reports/omeprazole-market/2477

The profiling enfolds key information of the companies which comprises of business overview, products and services, key financials and recent news and developments. Conclusively, the report titled "Omeprazole Market - Global Demand Analysis & Opportunity Outlook 2027", analyses the overall omeprazole industry to help new entrants to understand the details of the market. In addition to that, this report also guides existing players looking for expansion and major investors looking for investment in the global omeprazole market in the near future.

About Research Nester

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment, etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.

Contact Us

AJ Daniel
Email: info@researchnester.com
U.S. Phone: [+1 646 586 9123]
U.K. Phone: [+44 203 608 591]

The post Omeprazole Market Size, Share, Trends, Analysis Report And Future Predictions appeared first on America News Hour .

COMTEX_405909716/2606/2022-04-19T02:57:52

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

/zigman2/quotes/206812383/delayed
AU : Australia: Sydney
$ 0.70
-0.02 -2.10%
Volume: 0.00
Feb. 1, 2021 10:22a
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$133.08 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/209301288/composite
US : U.S.: NYSE
$ 3.36
+0.18 +5.66%
Volume: 544,472
July 1, 2022 4:00p
P/E Ratio
329.41
Dividend Yield
N/A
Market Cap
$963.30 million
Rev. per Employee
$299,742
loading...
/zigman2/quotes/202813279/delayed
CA : Canadian Securities Exchange
$ 3.74
+0.14 +3.89%
Volume: 4,210
June 30, 2022 1:05p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$6.26 million
Rev. per Employee
N/A
loading...

This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.